Ocean Biomedical (OCEAW) Stock Price, News & Analysis

Company Overview

Ocean Biomedical (NASDAQ: OCEAW) is a clinical-stage biotechnology company dedicated to developing vaccine and immunotherapeutic candidates aimed at preventing and treating antibiotic-resistant bacterial infections. The company’s proprietary antigen discovery platform leverages structure-based design to generate multivalent vaccine candidates targeting critical hospital-acquired pathogens such as Acinetobacter baumannii, Pseudomonas aeruginosa and Staphylococcus aureus.

Ocean Biomedical’s pipeline currently consists of preclinical programs focused on advancing lead vaccine candidates into investigational new drug (IND)-enabling studies. By combining in silico antigen selection with in vivo validation models, the company seeks to optimize immunogenicity and confer protective efficacy in high-risk patient populations where conventional antibiotics may be ineffective.

To accelerate its development timeline, Ocean Biomedical collaborates with academic research centers and contract manufacturing organizations to support scale-up and regulatory planning. Its executive team brings together seasoned professionals in vaccine research, clinical development and regulatory affairs, united by the goal of addressing the urgent global challenge of antimicrobial resistance through innovative preventative strategies.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 42,967 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:OCEAW
• CIK: 1869974
• Web: www.oceanbiomedical.com
• Phone: 401-444-7375
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A